GET IN TOUCH

  • Fields marked with an * are mandatory

newsletter sign-up

  • Fields marked with an * are mandatory

ecco

THE LIFE SCIENCE ENERGY EFFICIENCY SPECIALISTS

EECO2 is a leading global provider of researched, tested and proven engineered efficiency solutions for the pharmaceutical, biotech and other high tech industries.

Our team of dedicated experts have a wealth of experience in supporting organisations to substantially reduce energy and water consumption, along with associated greenhouse gas and CO2 emissions, whilst reducing costs and maintaining or improving industry compliance and safety.

Project scope can span from opportunity identification, monitoring, control and initial concept development through to detailed design, installation, commissioning and validation.

Find out more

WHAT WE DO

EECO2’s core solutions can be classified into four key benefit areas as shown below.  Click on a solution to find out more.

Find out more

THE RESULTS WE DELIVER

Client: Sterile pharmaceutical manufacturer |Location: Australia |Sector: PHARMACEUTICAL MANUFACTURING

Project Brief

Existing HVAC system designed to provide Grade A room conditions at high energy cost. Process changes resulted in requiring a Grade C room as background for a BFS filling line.

OUR RESULTS

Energy savings identified (per year)

Energy savings identified (per year)

455,000 kWh

Energy cost savings identified (per year)

Energy cost savings identified (per year)

$63,000 USD

Emissions reduction (per year)

Emissions reduction (per year)

387 tonnes

of CO2


Client: Global pharmaceutical company |Location: USA |Sector: PHARMACEUTICAL MANUFACTURING

Project Brief

Our brief was to reduce energy demand without compromising on quality or compliance.

OUR RESULTS

Energy savings delivered (per year)

Energy savings delivered (per year)

1,950 mWh

Energy cost savings (per year)

Energy cost savings (per year)

$135,000

Emissions reduction (per year)

Emissions reduction (per year)

917 tonnes

of CO2


Client: Global pharmaceutical manufacturer |Location: United Kingdom |Sector: PHARMACEUTICAL MANUFACTURINGBIOPHARMACEUTICAL MANUFACTURING

Project Brief

EECO2 were commissioned to examine, quantify and report on the opportunities for energy and water usage reduction at a UK vaccine manufacturing facility.

Key objectives included identifying and prioritising ‘quick win’ improvements that could be implemented immediately.

OUR RESULTS

Energy savings identified (per year):

Energy savings identified (per year):

4,283,000 kWh

23% reduction in site energy usage

Energy cost savings identified (per year):

Energy cost savings identified (per year):

£322,000

Water savings identified (per year):

Water savings identified (per year):

13,674 m3

52% reduction in site water consumption


Client: Global pharmaceutical manufacturer |Location: Italy |Sector: PHARMACEUTICAL MANUFACTURING

Project Brief

EECO2 were commissioned to deliver an HVAC energy focussed assessment of a pharmaceutical manufacturing site working together with the site energy/engineering team and other stakeholders.

The HVAC energy assessment is a proven process that guides the site team to identify and prioritise significant energy and carbon projects that have been discussed in detail and are viable for implementation. The assessment had a scope of reviewing the HVAC energy consumption associated with both GMP (sterile product manufacturing) and non-GMP facilities. It covers AHU, distribution systems and BMS controls and the related energy usage associated with conditioning and moving the air.

OUR RESULTS

Energy savings identified (per year):

Energy savings identified (per year):

13,621,000 kWh

(13,621 MWh)

Energy cost savings identified (per year):

Energy cost savings identified (per year):

€944,000

20% reduction in site energy costs

Emissions reduction (per year):

Emissions reduction (per year):

3,518 tonnes

of CO2 emissions


Client: Global pharmaceutical company |Location: United Kingdom |Sector: PHARMACEUTICAL MANUFACTURING

Project Brief

Our client had an issue with very high energy demand driven by the original HVAC system design which was also unable to meet product critical relative humidity conditions during summer months.

OUR RESULTS

Energy savings delivered (per year)

Energy savings delivered (per year)

1,500 mWh

Energy cost savings (per year)

Energy cost savings (per year)

£58,000

Emissions reduction (per year)

Emissions reduction (per year)

686 tonnes

of CO2


Client: Global pharmaceutical manufacturer |Location: United Kingdom |Sector: PHARMACEUTICAL MANUFACTURINGRESEARCH & DEVELOPMENT LABS

Project Brief

Our client was experiencing high energy demand driven by high volumes of treated fresh air to a large number of fume cupboards operating 24/7.

OUR RESULTS

Energy savings delivered (per year)

Energy savings delivered (per year)

293,000 kWh

Energy cost savings (per year)

Energy cost savings (per year)

£12,000

Emissions reduction (per year)

Emissions reduction (per year)

75.4 tonnes

of CO2


Client: Global Pharmaceutical Manufacturer |Location: Singapore |Sector: PHARMACEUTICAL MANUFACTURING

Project Brief

EECO2 was tasked to reduce energy demand at the client site, without compromising on compliance or laboratory safety.
The client site had very high energy demands, driven by original HVAC design and layout with high air change rates and fresh air volumes.

OUR RESULTS

Energy savings identified (per year):

Energy savings identified (per year):

2,200 MWh

Energy cost savings identified (per year):

Energy cost savings identified (per year):

$347,000

Emissions reduction (per year):

Emissions reduction (per year):

985 tonnes

of carbon emissions


Client: Global Pharmaceutical Manufacturer |Location: Kenya |Sector: PHARMACEUTICAL MANUFACTURING

Project Brief

EECO2 specialises in identifying and delivering energy savings in highly regulated environments for global businesses desiring to reduce energy consumption, cost & carbon footprint.  EECO2 supported this Top 10 Pharmaceutical Manufacturer in delivering Global Energy Reduction Projects.

OUR RESULTS

Energy savings identified (per year):

Energy savings identified (per year):

478,072 kWh

Energy cost savings identified (per year):

Energy cost savings identified (per year):

8,667,436 KES

21% reduction in site energy costs

Emissions reduction (per year):

Emissions reduction (per year):

182 tonnes

of CO2 emissions


Client: Global Pharmaceutical Company |Location: Philadelphia, USA |Sector: RESEARCH & DEVELOPMENT LABS

Project Brief

EECO2 was appointed to perform a HVAC energy audit and deliver a prioritised implementation plan for a large R&D facility located in Philadelphia. This was to allow the client to allocate budgets and resources to meet a phased implementation plan for the next 3 years in order to deliver the benefits identified.

OUR RESULTS

Energy savings identified (per year):

Energy savings identified (per year):

30,995MWh

Energy cost savings identified (per year):

Energy cost savings identified (per year):

$1,459,000

22% reduction in site energy costs

Emissions reduction (per year):

Emissions reduction (per year):

11,304 tonnes

of carbon emissions


Client: Global Pharmaceutical Manufacturer |Location: United Kingdom |Sector: PHARMACEUTICAL MANUFACTURING

Project Brief

EECO2 performed an ESOS audit, feasibility study and completed energy saving projects on a client site, which focussed on the buildings HVAC systems.

The Energy Savings Opportunity Scheme (ESOS) is the UK’s response to Article 8 of the European Commission’s Energy Efficiency Directive. It is a mandatory energy assessment scheme for organisations in the UK that meet the qualification criteria. The aim is to cut carbon emissions, by requiring large businesses to identify energy reduction measures and make energy savings. ESOS assessments are audits of the energy used by their buildings, industrial processes and transport to identify cost-effective energy saving measures.

OUR RESULTS

Energy savings identified (per year):

Energy savings identified (per year):

2.5 MWh

17% reduction in site energy consumption

Energy cost savings identified (per year):

Energy cost savings identified (per year):

£ 180,000

15% reduction in site energy costs

Emissions reduction (per year):

Emissions reduction (per year):

735 tonnes

of CO2


TESTIMONIALS

You always open our eyes to the savings opportunities that exist and how to go about implementing them. Thanks.

Client Senior Manager

Global top 10 pharmaceutical company

The EECO2 team demonstrated a thorough understanding of laboratory air systems. The data obtained was instrumental in formulating our energy reduction strategy… also their flexibility (weekend working) was appreciated.

Site Facilities Manager

Global pharmaceutical manufacturer, UK

It’s going to be a tough year and to know that we have such a good team supporting some of these changes makes the job a lot easier.

Manufacturing Support Manager

Global pharmaceutical manufacturer, South Africa

The service provided by EECO2 was clearly explained by Keith during the initial phone meeting. Everything which was promised in the contract was delivered within quoted price and timeline. EECO2 has recognised multiple savings opportunity for us.

Procurement Manager

Global pharmaceutical manufacturer

I have worked with EECObefore, but in the years since they have enhanced and refined their methodology to drive a greater value proposition. Nice job Rob and team, you guys exceeded our expectations!

Engineering Director

Global pharmaceutical manufacturer

Great job guys.  Imagine if this is indicative of the savings that could be achieved at every biologics site? That water target suddenly looks easy!

EHS Director

Global pharmaceutical manufacturer

The engineering team at EECO2 are easy to work with and have great experience in the field. Their advice is based in real world experience that is clear to understand and is applicable.

Site Energy Lead

Consumer health company

LATEST NEWS AND VIEWS

News article
EECO2 ATTENDS INTERPHEX AND SEAI ENERGY SHOW 2018

Posted on

Last week, the EECO2 team attended both INTERPHEX in New York City and SEAI’s Energy Show in Dublin. INTERPHEX was a huge event – expected to reach 10000 participants this year. EECO2’s Managing Director Rob was able to connect and network with industry experts and learn more about the latest technology in the Life Science…

Read more...

News article
EECO2 obtains gold corporate social responsibility supplier sustainability rating

Posted on

To make it easier for our clients to analyse and monitor our social and environmental performance, EECO2 have undergone an extensive independent assessment by EcoVadis, which covers the management of labour rights, fair business practices, anti-bribery and corruption, environment and sustainable procurement. EcoVadis is a company that brings buyers and suppliers together to efficiently drive…

Read more...

Take a look at our latest #News update, where we tell you what we thought of #INTERPHEX and #EnergyShow18 and explain how a @SEAI_ie Business Grant could help reduce your energy project costs! https://t.co/8oUOZjxzZL #energyefficiency #Sustainability #pharma

Enjoying @SEAI_ie #EnergyShow18 #energyefficiency #Sustainability

Hoping to make some interesting connections at #interphex2018. If your company needs support reducing emissions and energy consumption, have a word with Rob @bobbyraywallace – he is at #interphex today! @interphex #energyefficiency #sustainability


READ ALL NEWS

OUR CLIENTS

Aesica

Allergan

Amgen

AstraZeneca

Catalent

Eli Lilly

GlaxoSmithKline

Novartis

Pfizer

Pharmavite

Purogenix

Sanofi